Becton Dickinson
About: Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Employees: 73,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
2% less capital invested
Capital invested by funds: $62.2B [Q2] → $60.9B (-$1.31B) [Q3]
8% less repeat investments, than reductions
Existing positions increased: 551 | Existing positions reduced: 597
3% less funds holding
Funds holding: 1,556 [Q2] → 1,511 (-45) [Q3]
4.65% less ownership
Funds ownership: 91.78% [Q2] → 87.13% (-4.65%) [Q3]
15% less call options, than puts
Call options by funds: $183M | Put options by funds: $216M
27% less first-time investments, than exits
New positions opened: 120 | Existing positions closed: 165
31% less funds holding in top 10
Funds holding in top 10: 16 [Q2] → 11 (-5) [Q3]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Evercore ISI Group Vijay Kumar 65% 1-year accuracy 30 / 46 met price target | 29%upside $290 | Outperform Maintained | 1 Oct 2024 |
Citigroup Joanna Wiensch 67% 1-year accuracy 2 / 3 met price target | 22%upside $275 | Buy Upgraded | 1 Oct 2024 |
Financial journalist opinion
Based on 24 articles about BDX published over the past 30 days
